EUR 0.06
(-5.84%)
Year | Net Income | Net Income Growth |
---|---|---|
2022 | -6.96 Million EUR | -3.82% |
2021 | -6.7 Million EUR | 19.23% |
2020 | -8.3 Million EUR | -4.22% |
2019 | -7.97 Million EUR | -137313.79% |
2018 | -5800.00 EUR | 11.79% |
2017 | -6575.00 EUR | -9.49% |
2016 | -6005.00 EUR | 8.54% |
2015 | -6566.00 EUR | -33.02% |
2014 | -4936.00 EUR | 99.85% |
2013 | -3.19 Million EUR | 4.72% |
2012 | -3.35 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 Q2 | - EUR | 0.0% |
2022 Q4 | -3.06 Million EUR | 0.0% |
2022 Q2 | -3.9 Million EUR | 0.0% |
2022 FY | -6.96 Million EUR | -3.82% |
2021 Q4 | -2.49 Million EUR | 0.0% |
2021 Q2 | -4.21 Million EUR | 0.0% |
2021 FY | -6.7 Million EUR | 19.23% |
2020 Q2 | -3.54 Million EUR | 0.0% |
2020 FY | -8.3 Million EUR | -4.22% |
2020 Q4 | -4.76 Million EUR | 0.0% |
2019 Q4 | -3.85 Million EUR | 0.0% |
2019 FY | -7.97 Million EUR | -137313.79% |
2019 Q2 | -4.11 Million EUR | 0.0% |
2018 Q2 | -2710.00 EUR | 0.0% |
2018 FY | -5800.00 EUR | 11.79% |
2018 Q4 | -3090.00 EUR | 0.0% |
2017 Q4 | -3330.00 EUR | 0.0% |
2017 FY | -6575.00 EUR | -9.49% |
2017 Q2 | -3245.00 EUR | 0.0% |
2016 Q4 | -2446.00 EUR | 0.0% |
2016 FY | -6005.00 EUR | 8.54% |
2016 Q2 | -3559.00 EUR | 0.0% |
2015 FY | -6566.00 EUR | -33.02% |
2015 Q2 | -2727.00 EUR | 0.0% |
2015 Q4 | -3839.00 EUR | 0.0% |
2014 FY | -4936.00 EUR | 99.85% |
2014 Q4 | -2561.00 EUR | 0.0% |
2014 Q2 | -2375.00 EUR | 0.0% |
2013 Q4 | -1540.00 EUR | 99.81% |
2013 FY | -3.19 Million EUR | 4.72% |
2013 Q3 | -798 Thousand EUR | -48175.86% |
2013 Q2 | -1653.00 EUR | 99.79% |
2013 Q1 | -798 Thousand EUR | 0.0% |
2012 FY | -3.35 Million EUR | 0.0% |
2012 Q1 | -837.5 Thousand EUR | 0.0% |
2012 Q2 | -837.5 Thousand EUR | 0.0% |
2012 Q3 | -837.5 Thousand EUR | 0.0% |
2012 Q4 | -798 Thousand EUR | 4.72% |
2011 Q4 | -837.5 Thousand EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Crossject Société Anonyme | -8.63 Million EUR | 19.368% |
Spineway SA | -6.51 Million EUR | -6.989% |
Amplitude Surgical SA | 1.5 Million EUR | 564.333% |
Sartorius Stedim Biotech S.A. | 309.7 Million EUR | 102.249% |
EssilorLuxottica Société anonyme | 2.28 Billion EUR | 100.304% |
bonyf N.V. | -1.04 Million EUR | -566.695% |